Its listed rate should not rise solely with dose
PubMed laboratory research record [PMID: 38231641] PubMed record related to this compound for laboratory literature review
In addition to many GLP-1-based pharmacotherapies being tested in clinical settings for the treatment of obesity, GLP-1R agonists are successfully used in the clinic to treat type 2 diabetes mellitus (T2DM) and its related complications such as diabetic nephropathy [37, 39, 40]
Brar PC, Heksch R, Cossen K, et al
Most BCBS plans do NOT cover Zepbound for weight loss, but some employer-sponsored and state employee plans do
Work with your doctor to plan a treatment that includes supplements, meds, and other therapies